SANOFI 75.810 € (+0,74 %)
GETLINK SE 18.730 € (+1,19 %)
AKZO NOBEL 60.800 € (+1,00 %)
ASR NEDERLAND 66.560 € (-0,03 %)
CAPGEMINI 91.900 € (+0,37 %)
SHELL PLC 33.885 € (-0,24 %)
GENFIT 12.940 € (+22,31 %)
ASM INTERNATIONAL 975.600 € (+4,10 %)
TECHNIP ENERGIES 34.520 € (+3,42 %)
AIR LIQUIDE 180.300 € (+0,16 %)
AHOLD DEL 35.920 € (-0,66 %)
AB SCIENCE 0.773 € (+0,78 %)
ING GROEP N.V. 28.290 € (+0,21 %)
ALLFUNDS GROUP 8.575 € (+0,53 %)
MICHELIN 34.840 € (+0,35 %)
CROSSJECT 1.800 € (+0,67 %)
SBM OFFSHORE 30.680 € (+2,40 %)
DSM FIRMENICH AG 85.000 € (+2,29 %)
ACCOR 50.900 € (+0,35 %)
VALEO 13.275 € (+2,55 %)
VOLTALIA 7.200 € (+1,27 %)
AIR FRANCE -KLM 13.395 € (-0,37 %)
EUROPACORP 0.266 € (+9,92 %)
PHILIPS KON 24.690 € (+1,94 %)
ENGIE 27.730 € (+2,06 %)
LEGRAND 143.350 € (+1,59 %)
DNXCORP 17.750 € (-0,56 %)
UMG 18.995 € (-0,73 %)
ICADE 19.230 € (-0,83 %)
JCDECAUX 20.100 € (+1,11 %)
IPSEN 170.700 € (-0,23 %)
EUROCOMMERCIAL 27.450 € (0,00 %)
GECINA 72.800 € (-0,21 %)
UNILEVER 54.080 € (-0,39 %)
ADYEN 862.300 € (+0,85 %)
TKH GROUP 43.820 € (+2,19 %)
ABC ARBITRAGE 5.260 € (+0,57 %)
L'OREAL 382.450 € (-1,42 %)
STELLANTIS NV 4.930 € (-3,47 %)
AMG 33.080 € (+2,61 %)
SPIE 52.750 € (+5,50 %)
HERMES INTL 1 641.000 € (-0,36 %)
FUGRO 9.475 € (+0,74 %)
EXAIL TECHNOLOGIES 122.500 € (+0,99 %)
ARCADIS 33.780 € (+2,80 %)
S.E.B. 48.780 € (+0,58 %)
DASSAULT SYSTEMES 18.495 € (-0,94 %)
ORANGE 15.860 € (-0,06 %)
RENAULT 26.370 € (+1,66 %)
WOLTERS KLUWER 57.620 € (+0,07 %)
AIRBUS 206.150 € (+1,10 %)
FRANCAISE ENERGIE 42.100 € (+5,25 %)
VALNEVA 2.337 € (+4,10 %)
APERAM 45.500 € (+3,60 %)
THALES 238.200 € (-0,92 %)
ARCELORMITTAL SA 58.600 € (+5,89 %)
AEGON 7.672 € (+0,87 %)
NN GROUP 75.940 € (-0,24 %)
DRONE VOLT 0.389 € (+2,42 %)
BOLLORE 4.144 € (+0,83 %) |
28/03/2023 14:00
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide CatheterFREMONT, CA / ACCESSWIRE / March 28, 2023 / Q'Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States. The Walrus BGC is a unique development in the field of Mechanical Thrombectomy procedures. It provides physicians with not only the known benefits of BGC use clinically, but unique to Walrus, superior ease of use in preparation in these urgent procedures. Importantly, Walrus enables the physicians to navigate the catheter into a more distal location easily and safely compared to other systems, which is associated with improved patient outcomes from stroke. "The anticipation of Walrus in our international markets has been enormous, and we look forward to the same performance and loyalty around Walrus we have been fortunate to experience in the United States," said King Nelson, Q'Apel Medical's CEO. "We are thrilled to be entering the EU and other international markets with Walrus and providing more physicians in more countries the unparalleled performance of our flagship catheter. This CE Mark certification represents a significant growth milestone for Q'Apel Medical providing access to new markets," commented Jodie Fam, Chief Marketing Officer & GM International. About Q'Apel Medical Q'Apel Medical designs highly innovative technologies for neurovascular interventions and unmet clinical needs. Q'Apel's portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System and Armadillo Radial Access System are dual-mode catheters and part of the SelectFlex™ Family of Neurovascular Catheters. These devices feature two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures. Media Contact: Jodie Fam +44 7500702108 jfam@qapelmedical.com Contact InformationJodie Fam SOURCE: Q'Apel Medical Inc. View source version on accesswire.com: https://www.accesswire.com/745686/QApel-Medical-Inc-Granted-CE-Mark-Under-MDR-for-Their-Walrus-Balloon-Guide-Catheter Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière